AKT1 and mesothelioma: In an in vitro study of PDGFR-β overexpressing mesothelioma cell lines, imatinib induced cytotoxicity and apoptosis, probably because of PDGFR-β inactivation and downstream AKT pathway inhibition (Wilmink and Richel, 2008).